Since the Angiopoietin-2 (Ang2)/Tyrosine-protein kinase receptor-2 (Tie2) kinase signaling pathway is pivotal in tumor angiogenesis 18, we investigated the influence of naringenin treatment on this pathway. The gene discussed is ANGPT2; the disease is neoplasm.